Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins attending: chief complaint: dka major surgical or invasive procedure: femoral line history of present illness: ms. is a 58 year old female with history of poorly controlled type 1 diabetes, gastroparesis, cva, htn, hep c, and multiple prior admissions for dka presenting with dka. the patient is lethargic and unable to provide much history. however of further questioning patient reports n/v x3 over the last day as well as overall malaise. she reported poor po intake due to her "gastroparesis acting up" and did not take her last evening or this morning. she reported feeling more thirsty however drinking fluids made her feel nauseated. she noted her fs were very high this morning and also felt weak and dizzy per report. her daugter called ems. in the ed, initial vs were: hr 140s, bp 99/64. she was altered and had kussmaul breathing. she was oriented to person and was able to refuse a central line in her neck. a femoral cvl was placed. cxr was unrevealing for frank consolidation, ua was negative. ct head showed no acute process. vbg showed 7.10/13/98/4. labs showed anion gap of 39, na 124, k 6.2, hco3 < 5, cr of 2.5, wbc 15.3, lactate 5.5, trop < 0.01. repeat vbg 7.02/13/108/4 with lactate down to 4.8. she was given 2l ns, levofloxacin 750mg iv, bolus and gtt of 8u. repeat chem 7 showed gap of 35, k of 5.1. on arrival to the micu, patient's vs 96.4 131/77 109 20 99% ra. patient c/o mild abdominal pain and some overall weakness. reported feeling thirsty with polyuria at home. also reports dry cough x 2 years. denies fevers, chills, nausea, constipation, diarrhea, dysuria. review of systems: (+) per hpi (-) denies fever, chills, night sweats, recent weight loss or gain. denies headache, sinus tenderness, rhinorrhea or congestion. denies shortness of breath,dyspnea or wheezing. denies chest pain, chest pressure, palpitations. denies constipation, abdominal pain, diarrhea, dark or bloody stools. denies dysuria. denies arthralgias or myalgias. denies rashes or skin changes. past medical history: --type i dm: diagnosed at age 5, multiple hospitalizations for dka and hyperglycemia. complicated by retinopathy, severe peripheral neuropathy, and gastroparesis with marked constipation. --cva --diabetic polyneuropathy --hypertension --grave's disease, on mmi --seronegative arthritis, followed in rheumatology --hepatitis c, genotype 1a, biopsy with grade 1 inflammation, not on antiviral therapy; acquired from a blood transfusion in . had previous liver biopsy without significant fibrosis. never been treated with antivirals. --gerd --status post bilateral knee arthroscopies --migraine headaches --asthma --s/p tah --mouth surgery for removal of tumors --bilateral foot drop requiring wheelchair use social history: patient lives in an apt building with her daughter and 2 grandchildren(who are in their 20s). she has a home health aid. she has not worked for many years. she uses a wheelchair at baseline. she is a never smoker and does not use alcohol or drugs. family history: mother died of colon cancer. there are multiple family members with dm. physical exam: admission exam vitals: 96.4 131/77 109 20 99% ra general: alert, oriented, no acute distress : sclera anicteric, dry mm, oropharynx clear, eomi, neck: supple, jvp not elevated, no lad cv: tachycardic, normal s1 + s2, no murmurs, rubs, gallops lungs: clear to auscultation bilaterally, no wheezes, rales, ronchi abdomen: soft, non-distended, bowel sounds present, no organomegaly, minimally tender throughout, no rebound or guarding gu: foley in place ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema neuro: a&ox3. cnii-xii intact, 5/5 strength upper extremities, lower extremities weak and exam limited by patient effort. gait deferred. discharge exam afebrile, vss abdomen: mild suprapubic tenderness exam otherwise unchanged since admission pertinent results: admission exam: 01:05pm blood wbc-15.3*# rbc-3.67* hgb-10.9* hct-36.9 mcv-101* mch-29.8 mchc-29.6* rdw-13.4 plt ct-366 01:05pm blood neuts-83.2* lymphs-13.9* monos-2.4 eos-0.2 baso-0.4 01:05pm blood pt-11.6 ptt-38.5* inr(pt)-1.1 01:05pm blood glucose-769* urean-47* creat-2.5*# na-124* k-6.2* cl-80* hco3-less than 02:35pm blood glucose-727* na-128* k-5.1 cl-88* hco3-less than 04:43pm blood glucose-651* urean-44* creat-2.0* na-132* k-4.1 cl-97 hco3-5* angap-34* 06:07pm blood glucose-586* na-134 k-4.2 cl-100 07:10pm blood glucose-525* na-132* k-4.1 cl-101 hco3-10* angap-25* 01:05pm blood alt-29 ast-43* alkphos-100 totbili-0.4 01:05pm blood lipase-23 01:05pm blood ctropnt-<0.01 07:10pm blood ctropnt-<0.01 01:05pm blood albumin-4.0 calcium-8.9 phos-9.7*# mg-2.1 04:43pm blood calcium-7.1* phos-6.3*# mg-1.8 07:10pm blood calcium-7.2* phos-4.1# mg-1.6 02:35pm blood asa-neg ethanol-neg acetmnp-neg bnzodzp-neg barbitr-neg tricycl-neg 01:24pm blood type- po2-98 pco2-13* ph-7.10* caltco2-4* base xs--23 02:46pm blood type- po2-108* pco2-13* ph-7.02* caltco2-4* base xs--26 intubat-not intuba 12:20pm blood glucose-greater th lactate-5.5* k-6.7* 01:24pm blood lactate-5.6* 02:46pm blood lactate-4.8* admission ecg: sinus tachycardia. rate 135. na/ni. nonspecific st changes in inferior and lateral leads cxr: findings: single ap portable view of the chest is compared to previous exam from . given the limitations of the portable film with respiratory motion, the lungs are grossly clear. cardiomediastinal silhouette is normal. osseous and soft tissue structures are unremarkable. impression: no definite acute cardiopulmonary process. ct head w/o contrast: no definite acute intracranial process, although the exam is severely limited by motion artifact. discharge labs: 06:29am blood wbc-7.2 rbc-2.86* hgb-8.4* hct-27.9* mcv-97 mch-29.2 mchc-29.9* rdw-15.3 plt ct-314 06:29am blood glucose-429* urean-22* creat-1.3* na-131* k-5.0 cl-95* hco3-30 angap-11 06:29am blood calcium-8.7 phos-3.2 mg-1.8 brief hospital course: ms. is a 58 year old female with history of poorly controlled type 1 diabetes, gastroparesis, cva, htn, hep c, and multiple prior admissions for dka presenting with dka in the setting of missing doses. # dka/type i diabetes - patient presented with elevated sugars in the 700s, anion gap of 39, ketonuria. precipitant most likely due to patient not taking her correctly as she admitted to skipping her dose the evening prior and morning of admission. other possible triggers considered were infection given leukocytosis however patient afebrile and workup unrevealing. patient r/o mi. tox screen only positive for benzos (given in the ed). patient was given 8 units of as bolus then started on drip in the ed prior to transfer to the micu. patient was aggressively hydrated and continued on drip until her anion gap closed. drip was stopped and patient was restarted on her home dose of . her electrolytes were closely monitored and repleted appropriately. her blood sugars remained difficult to control as patient is sensitive to , but does not eat consistent and sometimes has late night snack around 10 or midnight. she is not consistent enough to teach carb counting. while on the floor, blood sugars fluctuated between 50 and 400s. patient tolerating (no nausea, ). she can feel when she is hyperglycemic or hypoglycemic, feeling tired and at times dizzy but never had confusion, altered mental status or increased anion gap. was consulted to help with management of her diabetes and recommended uptitration of her glargine and sliding scale and 3am blood glucose given late night snack. patient discharged home with new sliding scale and arranged close follow up with and pcp. # abdominal pain - patient reported diffuse mild abdominal pain on admission. likely related to dka and her gastroparesis. abdominal labs including lfts and lipase were unremarkable. she was restarted on her home regimen of reglan, hyocyamine sulfate. her pain improved to baseline and she was able to tolerate po. # acute kidney injury - cr elevated to 2.5 on arrival from baseline normal creatinine. this was likely related to volume depletion from n/v and poor po intake. her losartan was initially held and medications were renally dosed. she was volume recuscitated and cr improved to 1.1 and losartan was restarted. cr. was 1.3 on the day of discharge and patient encouraged to increase po fluid intake. please follow up as outpatient. # uti - on the day of discharge, patient developing suprapubic tenderness, no dysuria, no fever. u/a showed 13wbc, few bacteria, few yeast, sm leuks. in the setting of suprapubic tenderness, uncontrolled blood glucose, patient was started on cipro x 7 days. urine culture pending at the time of discharge. # hypertension - patient was normotensive on arrival. losartan was initially held then restarted after kidney function recovered. # peripheral neuropathy - continued on gabapentin, amitryptyline, percocet and flexeril. # grave's disease - continued methimazole 10 mg tablet tid. # asthma - continued home fluticasone-salmeterol 250-50 mcg/dose , montelukast 10 mg po daily, and albuterol prn. # gerd - continued pantoprazole 40 mg po qd # hyperlipidemia - continued simvastatin 10 mg po qhs # arthritis - continued sulfasalazine 1000mg po bid # hepatitis c - genotype 1a, acquired from a blood transfusion in . untreated, never been on antiviral therapy transitional issues: - code status: dnr/dni - follow up: clinic - pending studies: urine culture from addendum: urine culture contaminated medications on admission: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 2. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for constipation. 3. polyethylene glycol 3350 17 gram/dose powder sig: one (1) po daily (daily). 4. metoclopramide 10 mg tablet sig: one (1) tablet po qidachs (4 times a day (before and at bedtime)). 5. montelukast 10 mg tablet sig: one (1) tablet po daily (daily). 6. hyoscyamine sulfate 0.125 mg tablet, sublingual sig: three (3) tablet, sublingual sublingual (2 times a day). 7. losartan 100 mg tablet sig: one (1) tablet po once a day. 8. sulfasalazine 500 mg tablet sig: two (2) tablet po bid (2 times a day). 9. simvastatin 10 mg tablet sig: one (1) tablet po qhs (once a day (at bedtime)). 10. calcium carbonate 200 mg calcium (500 mg) tablet, chewable sig: one (1) tablet, chewable po daily (daily). 11. ferrous sulfate 325 mg (65 mg iron) tablet sig: one (1) tablet po once a day. 12. cholecalciferol (vitamin d3) 400 unit tablet sig: one (1) tablet po daily (daily). 13. oxycodone-acetaminophen 5-325 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for pain. 14. gabapentin 300 mg capsule sig: three (3) capsule po three times a day. 15. amitriptyline 50 mg tablet sig: one (1) tablet po hs (at bedtime). 16. methimazole 10 mg tablet sig: one (1) tablet po twice a day. 17. fluticasone-salmeterol 250-50 mcg/dose disk with device sig: one (1) disk with device inhalation (2 times a day). 18. cyclobenzaprine 10 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for pain. 19. zolmitriptan 2.5 mg tablet sig: one (1) tablet po once a day. 20. hydroxyzine hcl 25 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for itching. 21. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 22. lantus 100 unit/ml solution sig: one (1) 10 subcutaneous qam. 23. lantus 100 unit/ml solution sig: one (1) 8 subcutaneous qpm. 25. prochlorperazine maleate 10 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for nausea. 26. lispro 100 unit/ml solution sig: as directed units subcutaneous four times a day: per sliding scale. discharge medications: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) as needed for constipation. 2. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for constipation. 3. miralax 17 gram/dose powder sig: one (1) po once a day as needed for constipation. 4. metoclopramide 10 mg tablet sig: one (1) tablet po qidachs (4 times a day (before and at bedtime)). 5. montelukast 10 mg tablet sig: one (1) tablet po daily (daily). 6. hyoscyamine sulfate 0.375 mg capsule,extended release 12 hr sig: one (1) capsule,extended release 12 hr po bid (2 times a day). 7. losartan 50 mg tablet sig: two (2) tablet po daily (daily). 8. sulfasalazine 500 mg tablet sig: two (2) tablet po bid (2 times a day). 9. simvastatin 10 mg tablet sig: one (1) tablet po daily (daily). 10. calcium carbonate 200 mg calcium (500 mg) tablet, chewable sig: one (1) tablet, chewable po daily (daily). 11. ferrous sulfate 300 mg (60 mg iron) tablet sig: one (1) tablet po daily (daily). 12. cholecalciferol (vitamin d3) 400 unit tablet sig: one (1) tablet po once a day. 13. percocet 5-325 mg tablet sig: one (1) tablet po twice a day as needed for pain. 14. gabapentin 300 mg capsule sig: three (3) capsule po three times a day. 15. amitriptyline 25 mg tablet sig: two (2) tablet po hs (at bedtime). 16. methimazole 10 mg tablet sig: one (1) tablet po bid (2 times a day). 17. fluticasone-salmeterol 250-50 mcg/dose disk with device sig: one (1) puff inhalation (2 times a day). 18. cyclobenzaprine 10 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for pain. 19. zolmitriptan 2.5 mg tablet sig: one (1) tablet po once a day as needed for pain. 20. hydroxyzine hcl 25 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for itching. 21. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 22. ondansetron hcl 4 mg tablet sig: one (1) tablet po q8h (every 8 hours) as needed for nausea. disp:*30 tablet(s)* refills:*0* 23. sliding scale lantus 12 units every morning; 17 units every evening humalog: see attached sliding scale 24. sliding scale humalog qam: 81-120 11 u 121-170 12 u 171-220 13u 221-270 14 u 271-320 15u 321-370 17 u 371-420 19 u 421-440 21 u lunch: 81-120 5 u 121-170 6 u 171-220 7 u 221-270 8 u 271-320 9 u 321-370 10 u 371-420 11 u 421-440 13 u dinner: 81-120 3 u 121-170 4 u 171-220 5 u 221-270 6 u 271-320 7 u 321-370 9 u 371-420 11 u 421-440 13 u 10pm: 221-270 2 u 271-320 6 u 321-370 7 u 371-420 8 u 421-440 10 u 3am: 221-270 2 u 271-320 6 u 321-370 7 u 371-420 8 u 421-440 10 u 25. cipro 500 mg tablet sig: one (1) tablet po twice a day for 7 days. disp:*14 tablet(s)* refills:*0* discharge disposition: home with service facility: uphams corner home care discharge diagnosis: primary diabetic ketoacidosis diabetes mellitus type 1 gastroparesis secondary: h/o stroke diabetic neuropathy discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: out of bed with assistance to chair or wheelchair. discharge instructions: ms. , it was a pleasure participating in your care at . you were admitted after you had high blood sugar from missing doses. we treated you with drip in the intensive care unit and made changes to your regimen. you had discomfort with urination. we are treating your uti with antibiotics. we made the following changes to your medications: changed humalog sliding scale changed lantus dose stopped compazine as needed for nausea started zofran as needed for nausea started ciprofloxacin (last day ) followup instructions: pcp : at 3:00pm with: ,md location: uphams corner health center address: , , phone: endocrinology appointment: wednesday, at 4pm with , np location:one place , phone: procedure: venous catheterization, not elsewhere classified diagnoses: esophageal reflux urinary tract infection, site not specified unspecified essential hypertension chronic hepatitis c without mention of hepatic coma acute kidney failure, unspecified asthma, unspecified type, unspecified polyneuropathy in diabetes personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits do not resuscitate status toxic diffuse goiter without mention of thyrotoxic crisis or storm diabetes with neurological manifestations, type i [juvenile type], uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with ketoacidosis, type i [juvenile type], uncontrolled background diabetic retinopathy gastroparesis other acquired deformities of ankle and foot other specified arthropathy, site unspecified wheelchair dependence 

Answer: The patient is high likely exposed to